Arsenic trioxide inhibits nuclear receptor function via SEK1/JNK-mediated RXRalpha phosphorylation

Koren K Mann1, Alessandra M S Padovani, Qi Guo

  • 1Montréal Centre for Experimental Therapeutics in Cancer, Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, McGill University, Montréal, Québec, Canada.

Insights

Arsenic trioxide (As2O3) inhibits retinoic acid receptor signaling in acute promyelocytic leukemia cells by phosphorylating RXRalpha. This phosphorylation, particularly at serine 32, blocks gene transcription and may inform new therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Pharmacology

Background:

  • Acute promyelocytic leukemia (APL) is treated with arsenic trioxide (As2O3) and retinoic acid.
  • Previous studies indicated potential antagonism between As2O3 and retinoic acid in vitro.
  • Nuclear receptors play critical roles in cellular signaling and gene regulation.

Purpose of the Study:

  • To investigate the molecular mechanisms by which As2O3 affects nuclear receptor signaling, specifically the retinoic acid receptor (RAR).
  • To determine if As2O3-induced inhibition of transcription is mediated by phosphorylation of the retinoid X receptor alpha (RXRalpha).
  • To explore the role of c-Jun N-terminal kinase (JNK) in As2O3-induced effects on RXRalpha.

Main Methods:

  • In vitro transcription assays to measure ligand-induced receptor activity.
  • In vivo labeling and phosphoamino acid analysis to detect RXRalpha phosphorylation.
  • Pharmacologic and genetic inhibition of JNK signaling pathways.
  • Mutational analysis of RXRalpha to identify key phosphorylation sites.

Main Results:

  • As2O3 inhibited ligand-induced transcription of RAR and other nuclear receptors that heterodimerize with RXRalpha.
  • As2O3 specifically phosphorylated RXRalpha on serine residues in the N-terminal ABC region.
  • Inhibition of JNK activation reduced As2O3-induced RXRalpha phosphorylation and blocked transcriptional inhibition.
  • Phosphorylation of serine 32 (S32) on RXRalpha was found to be primarily responsible for the observed inhibition of transcription.

Conclusions:

  • As2O3 inhibits RXRalpha-mediated transcription through direct phosphorylation of RXRalpha, particularly at S32.
  • JNK signaling is involved in As2O3-induced RXRalpha phosphorylation and subsequent transcriptional inhibition.
  • These findings offer insights into the development of combined chemotherapeutic regimens for APL and the molecular basis of arsenic-induced carcinogenesis.

Related Concept Videos

Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.0K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.5K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.4K
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
8.6K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
6.7K